Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lipoprotein (a)]

K Makino1, A Noma

  • 1Department of Laboratory Medicine, Gifu University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 1, 1994
PubMed
Summary

Lipoprotein (a) is a key risk factor for cardiovascular disease due to its structure and similarity to plasminogen. Further research is needed to understand its role and develop drugs to lower its levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EAD and DAD mechanisms analyzed by developing a new human ventricular cell model.

Progress in biophysics and molecular biology·2014
Same author

The nonlinear elastic and viscoelastic passive properties of left ventricular papillary muscle of a guinea pig heart.

Journal of the mechanical behavior of biomedical materials·2011
Same author

Role of Ca2+ transporters and channels in the cardiac cell volume regulation.

Annals of the New York Academy of Sciences·2007
Same author

Modelling Cl- homeostasis and volume regulation of the cardiac cell.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2006
Same author

Intracellular Ca(2+) dynamics and sarcomere length in single ventricular myocytes.

Cell calcium·2004
Same author

Modulation of intracellular Na+ and Ca2+ induced by the cardiac Na+-Ca2+ exchanger in guinea pig ventricular myocytes.

The Japanese journal of physiology·2004

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Molecular Biology

Context:

  • Lipoprotein (a) [Lp (a)] is an LDL particle linked to apolipoprotein (a) [apo (a)].
  • Lp (a) is an independent risk factor for atherosclerotic cardiovascular disease.
  • Apo (a) shares significant homology with plasminogen, prompting interest in Lp (a)'s atherogenic and thrombotic mechanisms.

Purpose:

  • To review recent advances in understanding the atherogenicity and thrombogenicity mechanisms of Lp (a).
  • To highlight the need for further research into the physiological role of Lp (a).
  • To emphasize the urgent requirement for therapeutic strategies to reduce serum Lp (a) levels.

Summary:

  • Recent advances in the atherogenic and thrombotic mechanisms of Lp (a) are reviewed.
  • The physiological role of Lp (a) remains largely unknown and requires further investigation.
  • Developing drugs to lower serum Lp (a) concentrations is a critical unmet need.

Impact:

  • Provides a review of current knowledge on Lp (a) mechanisms.
  • Identifies knowledge gaps regarding Lp (a)'s physiological function.
  • Underscores the clinical need for Lp (a)-lowering therapies to mitigate cardiovascular risk.

Related Experiment Videos